Third Nitrosamine Implementation Oversight Group (NIOG) - meeting with pharmaceutical industry

• Date:
  Wednesday, 04 May 2022
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

The Nitrosamine Implementation Oversight Group (NIOG) was set up by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products.

The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion.

Documents

Agenda - Nitrosamine Implementation Oversight Group (NIOG) - third meeting with pharmaceutical industry

AdoptedReference Number: EMA/171422/2022

Presentation - Nitrosamine Implementation Oversight Group (NIOG) - third meeting with pharmaceutical industry

Industry presentation - Nitrosamine Implementation Oversight Group (NIOG) - third meeting with pharmaceutical industry

Highlights from the third meeting of the Nitrosamine Implementation Oversight Group (NIOG) and pharmaceutical Industry

Reference Number: EMA/171423/2022